Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 154

1.

Maternal death reviews: A retrospective case series of 90 hospital-based maternal deaths in 11 hospitals in Indonesia.

Baharuddin M, Amelia D, Suhowatsky S, Kusuma A, Suhargono MH, Eng B.

Int J Gynaecol Obstet. 2019 Feb;144 Suppl 1:59-64. doi: 10.1002/ijgo.12736.

PMID:
30815870
2.

Bright Mid-Infrared Photoluminescence from Thin-Film Black Phosphorus.

Chen C, Chen F, Chen X, Deng B, Eng B, Jung D, Guo Q, Yuan S, Watanabe K, Taniguchi T, Lee ML, Xia F.

Nano Lett. 2019 Mar 13;19(3):1488-1493. doi: 10.1021/acs.nanolett.8b04041. Epub 2019 Feb 20.

PMID:
30721622
3.

Stifling stateness: The Assad regime's campaign against rebel governance.

Martínez JC, Eng B.

Secur Dialogue. 2018 Aug;49(4):235-253. doi: 10.1177/0967010618768622. Epub 2018 Apr 11.

4.

Characterization of Two Novel Deletions Involving the 5' Region of the β-Globin Gene.

Waye JS, Hanna M, Hohenadel BA, Nakamura L, Walker L, Eng B.

Hemoglobin. 2017 Jul - Nov;41(4-6):239-242. doi: 10.1080/03630269.2017.1397015. Epub 2017 Nov 28.

PMID:
29182041
5.

α0-Thalassemia Due to a 90.7 kb Deletion (- -NFLD).

Waye JS, Eng B, Hanna M, Hohenadel BA, Nakamura L, Walker L.

Hemoglobin. 2017 May;41(3):218-219. doi: 10.1080/03630269.2017.1369987. Epub 2017 Sep 13.

PMID:
28838269
6.

3q27.3 Microdeletion syndrome: further delineation of the second region of overlap and atopic dermatitis as a phenotypic feature.

Jewell R, Eng B, Coates A, Hewitt S, Hobson E.

Clin Dysmorphol. 2017 Jul;26(3):154-156. doi: 10.1097/MCD.0000000000000177. No abstract available.

PMID:
28288024
7.

Novel Mutation of the Translation Initiation Codon of the α1-Globin Gene (ATG>AAG or HBA1:c.2T>A).

Waye JS, Eng B, Hanna M, Hohenadel BA, Nakamura L, Walker L.

Hemoglobin. 2016 Sep;40(5):369-370.

PMID:
27821014
8.

Clinical Next-Generation Sequencing Pipeline Outperforms a Combined Approach Using Sanger Sequencing and Multiplex Ligation-Dependent Probe Amplification in Targeted Gene Panel Analysis.

Schenkel LC, Kerkhof J, Stuart A, Reilly J, Eng B, Woodside C, Levstik A, Howlett CJ, Rupar AC, Knoll JHM, Ainsworth P, Waye JS, Sadikovic B.

J Mol Diagn. 2016 Sep;18(5):657-667. doi: 10.1016/j.jmoldx.2016.04.002. Epub 2016 Jul 2.

PMID:
27376475
9.

Mixed impact of Xpert(®) MTB/RIF on tuberculosis diagnosis in Cambodia.

Auld SC, Moore BK, Kyle RP, Eng B, Nong K, Pevzner ES, Eam KK, Eang MT, Killam WP.

Public Health Action. 2016 Jun 21;6(2):129-35. doi: 10.5588/pha.16.0001.

10.

Rollout of Xpert(®) MTB/RIF in Northwest Cambodia for the diagnosis of tuberculosis among PLHA.

Auld SC, Moore BK, Killam WP, Eng B, Nong K, Pevzner EC, Eam KK, Eang MT, Warren D, Whitehead SJ.

Public Health Action. 2014 Dec 21;4(4):216-21. doi: 10.5588/pha.14.0082.

11.

Sudanese (δβ)0-Thalassemia: Identification and Characterization of a Novel 9.6 kb Deletion.

Waye JS, Eng B, Got T, Hanna M, Hohenadel BA, Nakamura LM, Walker L.

Hemoglobin. 2015;39(5):368-70. doi: 10.3109/03630269.2015.1057736. Epub 2015 Jul 8.

PMID:
26154945
12.

Differences in solution dynamics between lens β-crystallin homodimers and heterodimers probed by hydrogen-deuterium exchange and deamidation.

Lampi KJ, Murray MR, Peterson MP, Eng BS, Yue E, Clark AR, Barbar E, David LL.

Biochim Biophys Acta. 2016 Jan;1860(1 Pt B):304-14. doi: 10.1016/j.bbagen.2015.06.014. Epub 2015 Jul 3.

13.

Krüppel-like factor 1: hematologic phenotypes associated with KLF1 gene mutations.

Waye JS, Eng B.

Int J Lab Hematol. 2015 May;37 Suppl 1:78-84. doi: 10.1111/ijlh.12356. Review.

PMID:
25976964
14.

α(+)-Thalassemia Due to a Frameshift Mutation of the α2-Globin Gene [codons 55/56 (+T) or HBA2: c.168dup].

Waye JS, Eng B, Hanna M, Hohenadel BA, Nakamura LM, Walker L.

Hemoglobin. 2015;39(3):209-10. doi: 10.3109/03630269.2015.1030410. Epub 2015 Apr 21.

PMID:
25897479
15.

Hb S/β+-thalassemia due to Hb sickle and a novel deletion of DNase I hypersensitive sites HS3 and HS4 of the β locus control region.

Amid A, Cheong M, Eng B, Hanna M, Hohenadel BA, Nakamura LM, Walker L, Odame I, Kirby-Allen M, Waye JS.

Haematologica. 2015 May;100(5):e166-8. doi: 10.3324/haematol.2014.117408. Epub 2015 Feb 14. No abstract available.

16.

Non-thalassemic phenotype associated with the -83 (G > A) mutation of the β-globin gene promoter (HBB: c.-133G > A).

Waye JS, Eng B, Hanna M, Hohenadel BA, Nakamura LN, Walker L.

Hemoglobin. 2014;38(6):447-8. doi: 10.3109/03630269.2014.976417.

PMID:
25405919
17.

The utility of stool cultures for diagnosing tuberculosis in people living with the human immunodeficiency virus.

Oramasionwu GE, Heilig CM, Udomsantisuk N, Kimerling ME, Eng B, Nguyen HD, Thai S, Keo C, McCarthy KD, Varma JK, Cain KP.

Int J Tuberc Lung Dis. 2013 Aug;17(8):1023-8. doi: 10.5588/ijtld.13.0061.

18.

Mild β(+)-thalassemia associated with two linked sequence variants: IVS-II-839 (T>C) and IVS-II-844 (C>A).

Waye JS, Eng B, Hellens L, Hohenadel BA, Nakamura LM, Walker L.

Hemoglobin. 2013;37(4):378-86. doi: 10.3109/03630269.2013.788511. Epub 2013 May 8.

PMID:
23651435
19.

Diagnostic testing for α-globin gene disorders in a heterogeneous North American population.

Waye JS, Eng B.

Int J Lab Hematol. 2013 Jun;35(3):306-13. doi: 10.1111/ijlh.12066. Review.

PMID:
23590659
20.

Normal Hb A2 β-thalassemia trait: frameshift mutation (HBB: c.187_251dup) in cis with the Hb A2' δ-globin gene missense mutation (HBD: c.49G>C).

Waye JS, Eng B, Hellens L, Hohenadel BA, Nakamura LM, Walker L.

Hemoglobin. 2013;37(2):201-4. doi: 10.3109/03630269.2012.763171. Epub 2013 Feb 11.

PMID:
23398055
21.

Cytotoxic and genotoxic characterization of titanium dioxide, gadolinium oxide, and poly(lactic-co-glycolic acid) nanoparticles in human fibroblasts.

Setyawati MI, Khoo PK, Eng BH, Xiong S, Zhao X, Das GK, Tan TT, Loo JS, Leong DT, Ng KW.

J Biomed Mater Res A. 2013 Mar;101(3):633-40. doi: 10.1002/jbm.a.34363. Epub 2012 Aug 28.

PMID:
22927021
22.

Training more doctors in the developed English speaking world: impact on post-graduate training and employment.

Eng B.

Med Teach. 2012;34(7):595. doi: 10.3109/0142159X.2012.675103. Epub 2012 Apr 10. No abstract available.

PMID:
22489972
23.

Medical school places: distribution and availability of places in the UK.

Eng B.

Med Teach. 2012;34(5):426. doi: 10.3109/0142159X.2012.669086. Epub 2012 Mar 28. No abstract available.

PMID:
22452279
24.

α(+)-Thalassemia trait caused by a frameshift mutation in exon 2 of the α2-globin gene [HBA2 c.244delT].

Waye JS, Walker L, Eng B.

Hemoglobin. 2012;36(2):205-7. doi: 10.3109/03630269.2012.656172. Epub 2012 Feb 29.

PMID:
22375514
26.

β+-Thalassemia trait due to a novel mutation in the β-globin gene promoter: -26 (A>C) [HBB c.-76A>C].

Waye JS, Nakamura-Garrett LM, Eng B, Kanavakis E, Traeger-Synodinos J.

Hemoglobin. 2011;35(1):84-6. doi: 10.3109/03630269.2010.529744.

PMID:
21250885
27.

Advancing translational research collaborations.

Portilla LM, Evans G, Eng B, Fadem TJ.

Sci Transl Med. 2010 Dec 22;2(63):63cm30. doi: 10.1126/scitranslmed.3001636.

PMID:
21178130
28.

Characterization of three novel delta chain hemoglobin variants and two delta-thalassemia alleles.

Frischknecht H, Troxler H, Dutly F, Walker L, Hohenadel BA, Eng B, Waye JS.

Hemoglobin. 2010;34(4):374-82. doi: 10.3109/03630269.2010.500966.

PMID:
20642335
29.

High level expression of functional human IgMs in human PER.C6 cells.

Tchoudakova A, Hensel F, Murillo A, Eng B, Foley M, Smith L, Schoenen F, Hildebrand A, Kelter AR, Ilag LL, Vollmers HP, Brandlein S, McIninch J, Chon J, Lee G, Cacciuttolo M.

MAbs. 2009 Mar-Apr;1(2):163-71. Epub 2009 Mar 24.

30.

alpha-Thalassemia caused by two novel splice mutations of the alpha2-globin gene: IVS-I-1 (G>A and G>T).

Waye JS, Eng B, Dutly F, Frischknecht H.

Hemoglobin. 2009;33(6):519-22. doi: 10.3109/03630260903333377.

PMID:
19958200
31.

Molecular characterization of a novel 55.1 kb (G)gamma((A)gammadeltabeta)(0)-thalassemia deletion in two Canadian families.

Voruganti I, Eng B, Waye JS.

Hemoglobin. 2009;33(6):422-7. doi: 10.3109/03630260903333088.

PMID:
19958187
32.

Three new beta-thalassemia mutations with varying degrees of severity.

Frischknecht H, Dutly F, Walker L, Nakamura-Garrett LM, Eng B, Waye JS.

Hemoglobin. 2009;33(3):220-5. doi: 10.1080/03630260903089060.

PMID:
19657836
33.

Characterisation of the British alpha 0-thalassaemia deletion: evidence of a founder effect in Newfoundland, Canada.

Eng B, Greenlay B, Waye JS.

Br J Haematol. 2009 Oct;147(1):150-2. doi: 10.1111/j.1365-2141.2009.07825.x. Epub 2009 Jul 20. No abstract available.

PMID:
19622095
34.

Impact of a public antiretroviral program on TB/HIV mortality: Banteay Meanchey, Cambodia.

Eng B, Cain KP, Nong K, Chhum V, Sin E, Roeun S, Kim S, Keo S, Heller TA, Varma JK.

Southeast Asian J Trop Med Public Health. 2009 Jan;40(1):89-92.

PMID:
19323039
35.

Systematic review on quality control for drug management programs: is quality reported in the literature?

Holtorf AP, McAdam-Marx C, Schaaf D, Eng B, Oderda G.

BMC Health Serv Res. 2009 Feb 25;9:38. doi: 10.1186/1472-6963-9-38. Review.

36.

Alpha+-thalassemia trait caused by a nonsense mutation in the alpha2-globin gene: codon 54 (CAG>TAG).

Eng B, Walker L, Waye JS.

Hemoglobin. 2009;33(1):72-4. doi: 10.1080/03630260802625980.

PMID:
19205977
37.

Hb North York [beta 117(G19)His-->Asp]: a new beta chain hemoglobin variant.

Waye JS, Walker L, Nakamura LM, Eng B, McFarlane A.

Hemoglobin. 2009;33(1):51-3. doi: 10.1080/03630260802625659.

PMID:
19205973
38.

Novel 27.9 kb alpha(0)-thalassemia deletion in a Filipino woman.

Waye JS, Greenlay B, Eng B.

Am J Hematol. 2009 Mar;84(3):197-8. doi: 10.1002/ajh.21349. No abstract available.

39.

Association between distance to HIV testing site and uptake of HIV testing for tuberculosis patients in Cambodia.

Kanara N, Cain KP, Chhum V, Eng B, Kim S, Keo S, Heller TA, Varma JK.

Int J Tuberc Lung Dis. 2009 Feb;13(2):226-31.

PMID:
19146752
40.

Systematic analysis of outcomes evaluations applied to drug management programs.

McAdam-Marx C, Schaaf DT, Holtorf AP, Eng B, Oderda GM.

Am J Manag Care. 2008 Nov;14(11 Suppl):SP36-45. Review.

41.

The potential effects of HEDIS performance measures on the quality of care.

Eddy DM, Pawlson LG, Schaaf D, Peskin B, Shcheprov A, Dziuba J, Bowman J, Eng B.

Health Aff (Millwood). 2008 Sep-Oct;27(5):1429-41. doi: 10.1377/hlthaff.27.5.1429.

PMID:
18780934
42.

Frameshift mutation in the alpha2-globin gene causing alpha+ -thalassemia: codon 49 (-GC).

Eng B, Waye JS.

Hemoglobin. 2008;32(3):315-7. doi: 10.1080/03630260701798359.

PMID:
18473249
43.

Characterization of a long-term rat mTAL cell line.

Eng B, Mukhopadhyay S, Vio CP, Pedraza PL, Hao S, Battula S, Sehgal PB, McGiff JC, Ferreri NR.

Am J Physiol Renal Physiol. 2007 Oct;293(4):F1413-22. Epub 2007 Aug 1.

44.

De novo mutation of the DHCR7 gene in a fetus with severe Smith-Lemli-Opitz (or RSH) syndrome.

Waye JS, Eng B, Potter MA, Nowaczyk MJ, McFadden D, Langlois S.

Am J Med Genet A. 2007 Aug 1;143A(15):1799-801. No abstract available.

PMID:
17595012
45.

Characterisation of a novel 49.3 kb Ggamma(Agamma delta beta)(0) -thalassaemia deletion in seven families of Asian descent.

Waye JS, Walker L, Kyriakopoulou LG, Potter MA, Eng B.

Br J Haematol. 2007 Jul;138(1):125-6. No abstract available.

PMID:
17555456
46.

Three new beta-globin gene promoter mutations identified through newborn screening.

Eng B, Walker L, Nakamura LM, Hoppe C, Azimi M, Lee H, Waye JS.

Hemoglobin. 2007;31(2):129-34.

PMID:
17486493
47.

Prenatal diagnosis of Smith-Lemli-Opitz syndrome (SLOS) by DHCR7 mutation analysis.

Waye JS, Eng B, Nowaczyk MJ.

Prenat Diagn. 2007 Jul;27(7):638-40.

PMID:
17441222
48.

Gene symbol: ARSA.

Waye JS, Eng B.

Hum Genet. 2007 Feb;120(6):913. No abstract available.

PMID:
17438611
49.

Gene symbol: ARSA.

Waye JS, Eng B.

Hum Genet. 2007 Feb;120(6):909. No abstract available.

PMID:
17438600
50.

High oxygen affinity hemoglobin variant in a Canadian family: Hb Bunbury [beta94(FG1)Asp-->Asn, GAC-->AAC].

Walker L, Eng B, McFarlane A, Waye JS.

Hemoglobin. 2007;31(1):101-3.

PMID:
17365011

Supplemental Content

Support Center